Search

Filters

Clear All
  • 19
  • 28
  • 2
  • 171

Phase

  • 5
  • 4
  • 2
  • 6
  • 4
  • 3
  • 157
  • 208
  • 67
  • 218
  • 2
  • 15
  • 4

Found 220 results for cancer

A listing of cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A Phase III Multicenter Open Label Randomized Controlled Trial of Cefoxitin versus Piperacillin-Tazobactam as Surgical Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy

18 years - 100 years
All genders
The purpose of this study is to figure out which commonly used antibiotic, cefoxitin or piperacillin-tazobactam, is better at decreasing the rate of surgical site infections after pancreatoduodenectomy.
 Assessing Exercise Behavior and Preferences Among Patients and Oncologists

Assessing Exercise Behavior and Preferences Among Patients and Oncologists

18 years - 90 years
Female
The purpose of this study is to understand the preferences and barriers surrounding exercise of both the patients and oncologists within Indiana University Simon Cancer Center. This information will establish gaps in our current care and provide important information to guide future pilot interventions.

Predicting Progression of Developing Myeloma in a High Risk-Screened Population (PROMISE)

40 years - 75 years
All genders
We will further study people who test positive for these early warning signs of multiple myeloma so that we can learn how to prevent them from developing into cancer.    Your participation may help researchers find new ways to prevent and treat blood cancer.  

A Phase 1a/1b Study of an Anti-IDO-1 Agent (LY3381916) Administered Alone or in Combination with Anti-PD-L1 Checkpoint Antibody (LY3300054) in Solid Tumors

18 years - 100 years
All genders
The purpose of this study is to evaluate the safety of the study drug LY3381916 administered alone or in combination with anti-programmed cell death ligand 1 (PD-L1) checkpoint antibody (LY3300054).

IUCRO-0042; Blood Drawing for Study of Peripheral Blood T-Lymphocytes and Other Parameters in patients with Metastatic Melanoma and Renal Cell Cancer with Spontaneous Regression

18 years - 100 years
All genders
The purpose of this trial is to collect peripheral blood from patients with metastatic melanoma and renal cell cancer who have experienced spontaneous regression in order to study immune response.

DEcisions about Cancer screening in Alzheimer's Disease (DECAD)

18 years - 100 years
All genders
The purpose of this study is to gain an understanding about the use of educational pamphlets by caregivers of women with dementia. This study will randomly assign caregivers to receive one of two different educational pamphlets and is designed to gather information on how caregivers make health care decisions for …

A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)

1 years - 21 years
All genders
This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come back or does not respond to treatment.

A Phase II Pilot Trial to Estimate Survival After a Non-total Body Irradiation (TBI) Based Conditioning Regimen in Patients Diagnosed With B-acute Lymphoblastic Leukemia (ALL) Who Are Pre-allogeneic Hematopoietic Cell Transplantation (HCT) Next-generation-sequence (NGS) Minimal Residual Disease (MRD) Negative

1 years - 25 years
All genders
This study will evaluate the use of non- TBI (total body irradiation) conditioning for B-ALL patients with low risk of relapse as defined by absence of NGS-MRD (next generation sequencing minimal residual disease) before receiving a hematopoietic cell transplant (HCT).

TestTrial123

20 years - 70 years
Accepts healthy volunteer
Female
    Cancer
201 - 210 of 220